UAE: Abu Dhabi’s cancer care centre receives prestigious JCI accreditation

The Fatima bint Mubarak Center, a standalone and dedicated facility for cancer care at Cleveland Clinic Abu Dhabi (CCAD), has received the prestigious Joint Commission International (JCI) three-year accreditation.

JCI accreditation is the gold standard for quality of care and patient safety in the global healthcare community. CCAD, part of the M42 network, received this accreditation last year making it the third consecutive time since 2016.

The Fatima bint Mubarak Centre, a state-of-the-art facility, provides patients with access to diagnostics and treatment options through world-class facilities across 24 clinical departments that include a range of cancer sub-specialties and programmes.

Getting the JCI recognition within the first year of operation strengthens the facility’s position as the benchmark for excellence and world-class care. It reinforces the centre’s commitment to excellence in healthcare and elevates its status as a pioneer in cutting-edge cancer care in the UAE and wider region.

“This accreditation is a testament to the hard work and dedication of our multidisciplinary teams and their steadfast focus on providing the best possible care to our patients – from day one. Being recognised by the world’s preeminent international accreditation body further cements our position as a healthcare leader providing world-class care closer to home,” said Dr Stephen Grobmyer, institute chair of the oncology institute at CCAD.

• Quality care for women every step of the way